BamSEC and AlphaSense Join Forces
Learn More

Dianthus Therapeutics Inc. – Indentures

NASDAQ: DNTH    
Share price (6/2/26): $81.57    
Market cap (6/2/26): $4.459 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 11 pages Dianthus Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.8
from S-3 41 pages Dianthus Therapeutics, Inc. Debt Securities Indenture Dated as of , 202 [ ], as Trustee
12/34/56
EX-4.1
from 8-K 11 pages Dianthus Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.8
from S-3 41 pages Dianthus Therapeutics, Inc. Debt Securities Indenture Dated as of , 202 [ ], as Trustee
12/34/56
EX-4.5
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.1
from 8-K 12 pages Dianthus Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 31 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 12 pages Dianthus Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-4/A 62 pages Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.2
from 8-K 4 pages Amendment No. 1 to Stockholder Rights Agreement
12/34/56
EX-4.1
from 8-A12B 74 pages Magenta Therapeutics, Inc. and Computershare Trust Company, N.A. as Rights Agent Stockholder Rights Agreement Dated as of March 31, 2023
12/34/56
EX-4
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.6
from S-3 49 pages Magenta Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], [●] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 48 pages Magenta Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], [●] Senior Debt Securities
12/34/56
EX-4.3
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.6
from S-3 49 pages Magenta Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 201[●] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 48 pages Magenta Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 201[●] Senior Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 62 pages Magenta Therapeutics, Inc. Second Amended and Restated Investors’ Rights Agreement April 2, 2018
12/34/56
EX-4.2
from DRS/A 62 pages Magenta Therapeutics, Inc. Second Amended and Restated Investors’ Rights Agreement April 2, 2018
12/34/56